Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

peckforton pharmaceuticals ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml

Estados Unidos - inglês - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 120 mg - diltiazem hydrochloride tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. diltiazem hydrochloride tablets are contraindicated in: - patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker - patients with second – or third-degree av block except in the presence of a functioning ventricular pacemaker - patients with hypotension (less than 90 mm hg systolic) - patients who have demonstrated hypersensitivity to the drug - patients which acute myocardial infarction and pulmonary congestion documents by x-ray on admission

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - dobutamine hydrochloride - infusion - 1mg/1ml

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - dobutamine hydrochloride - infusion - 5mg/1ml

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - dobutamine hydrochloride - solution for infusion - 1.2mg/1ml

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - dobutamine hydrochloride, quantity: 28 mg/ml (equivalent: dobutamine, qty 25 mg/ml) - injection, powder for - excipient ingredients: mannitol; water for injections - dobutrex is indicated is adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.

Israel - inglês - Ministry of Health

david margalit & co.ltd - dobutamine as hydrochloride - concentrate for solution for infusion - dobutamine as hydrochloride 12.5 mg/ml - dobutamine - dobutamine is indicated for patients who require a positive inotropic support in the short term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures, especially when a low cardiac output is associated with raised pulmonary pressure.

Zimbábue - inglês - Medicines Control Authority

fresenius kabi south africa (pty) ltd - dobutamine hydrochloride - injectable; injection - 250mg/20ml

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - dobutamine hydrochloride - solution for infusion - 12.5mg/1ml

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - dobutamine hydrochloride - solution for infusion - 5mg/1ml